Primary Site >> Biliary tract Cancer
Gene >> AES
|
|
|
|
|
|
|---|---|---|---|---|---|
|
Ref: Treatment of unresectable cholangiocarcinoma with gemcitabine-based transcatheter arterial chemoembolization (TACE): a single-institution experience. PMID: 17851723 |
Ref: OEM-TACE: a new therapeutic approach in unresectable intrahepatic cholangiocarcinoma. PMID: 19727937 |
Ref: An analysis of a second-line S-1 monotherapy for gemcitabine-refractory biliary tract cancer. PMID: 22469710 |
Ref: A randomized, multicenter, phase II study of vandetanib monotherapy versus vandetanib in combination with gemcitabine versus gemcitabine plus placebo in subjects with advanced biliary tract cancer: the VanGogh study. PMID: 25538178 |
Ref: Effectiveness and safety of sorafenib in the treatment of unresectable and advanced intrahepatic cholangiocarcinoma: a pilot study. PMID: 27783997 Ref: Axitinib for Gemcitabine-refractory Advanced Biliary Tract Cancer: Report of 5 Cases. PMID: 28668864 |
Ref: Predictive Value of Early Skin Rash in Cetuximab-Based Therapy of Advanced Biliary Tract Cancer. PMID: 28456898 Ref: Phase 1b investigation of the MEK inhibitor binimetinib in patients with advanced or metastatic biliary tract cancer. PMID: 29785570 Ref: The Efficacy and Safety of Apatinib Treatment for Patients with Unresectable or Relapsed Liver Cancer: a retrospective study. PMID: 30123344 Ref: Percutaneous hepatic perfusion (chemosaturation) with melphalan in patients with intrahepatic cholangiocarcinoma: European multicentre study on safety, short-term effects and survival. PMID: 30255257 |